RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Synthesis of Secondary and Tertiary Oxime Carbamate Derivatives and their Structure-Dependent Bioactivity

      한글로보기

      https://www.riss.kr/link?id=A105078748

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Biologically active novel piperidin-4-one oxime carbamates were synthesized from 3-ethyl-1-methyl-2,6-diphenylpiperidin-4-one oxime, 1,1′-carbonyldiimidazole (CDI), and primary or secondary amines in the presence of sodium hydride as base. Commercially available, cheaper, and safer CDI was utilized as carbonyl source, instead of toxic phosgene/triphosgene and carbon monoxide. The devised method is feasible for primary and secondary amines to make their corresponding oxime carbamate derivatives, through oxime–imidazolide intermediate, in high yield. When the antimicrobial activity of obtained oxime carbamate derivatives was investigated in comparison with streptomycin and amphotericin B as standards, the oxime carbamate containing heteroaromatic thiazole ring exhibits outstanding antimicrobial effectiveness, regardless of bacterial or fungal types.
      번역하기

      Biologically active novel piperidin-4-one oxime carbamates were synthesized from 3-ethyl-1-methyl-2,6-diphenylpiperidin-4-one oxime, 1,1′-carbonyldiimidazole (CDI), and primary or secondary amines in the presence of sodium hydride as base. Commercia...

      Biologically active novel piperidin-4-one oxime carbamates were synthesized from 3-ethyl-1-methyl-2,6-diphenylpiperidin-4-one oxime, 1,1′-carbonyldiimidazole (CDI), and primary or secondary amines in the presence of sodium hydride as base. Commercially available, cheaper, and safer CDI was utilized as carbonyl source, instead of toxic phosgene/triphosgene and carbon monoxide. The devised method is feasible for primary and secondary amines to make their corresponding oxime carbamate derivatives, through oxime–imidazolide intermediate, in high yield. When the antimicrobial activity of obtained oxime carbamate derivatives was investigated in comparison with streptomycin and amphotericin B as standards, the oxime carbamate containing heteroaromatic thiazole ring exhibits outstanding antimicrobial effectiveness, regardless of bacterial or fungal types.

      더보기

      참고문헌 (Reference)

      1 A. R. Kartritzky, 55 : 3205-, 1990

      2 A. Zega, 12 : 589-, 2005

      3 F. Giannessi, 46 : 303-, 2003

      4 A. B. Reiss, 13 : 3227-, 2006

      5 M. Arockia doss, 3 : 261-, 2015

      6 S. K. Sahu, 23 : 67-, 2014

      7 S. Savithiri, 2 : 403-, 2014

      8 R. Sivakumar, 23 : 3195-, 2013

      9 T. Maruthavanan, 27 : 238-, 2013

      10 S. B. Zaware, 35 : 1615-, 2011

      1 A. R. Kartritzky, 55 : 3205-, 1990

      2 A. Zega, 12 : 589-, 2005

      3 F. Giannessi, 46 : 303-, 2003

      4 A. B. Reiss, 13 : 3227-, 2006

      5 M. Arockia doss, 3 : 261-, 2015

      6 S. K. Sahu, 23 : 67-, 2014

      7 S. Savithiri, 2 : 403-, 2014

      8 R. Sivakumar, 23 : 3195-, 2013

      9 T. Maruthavanan, 27 : 238-, 2013

      10 S. B. Zaware, 35 : 1615-, 2011

      11 B. B. Cwynar, 14 : 203-, 2015

      12 Y. Q. Xie, 85 : 743-, 2015

      13 H. Dai, 56 : 10805-, 2008

      14 P. Adams, 65 : 567-, 1965

      15 A. F. Carley, 677-, 1989

      16 M. George, 123 : 10393-, 2001

      17 M. George, 18 : 7124-, 2002

      18 M. George, 19 : 1017-, 2003

      19 E. Carretti, 125 : 5121-, 2003

      20 D. P. N. Satchell, 4 : 231-, 1975

      21 V. Snieckus, 90 : 879-, 1990

      22 P. G. Jessop, 95 : 259-, 1995

      23 W. W. Cleland, 98 : 549-, 1998

      24 F. Tanaka, 102 : 4885-, 2002

      25 I. Vauthey, 41 : 6347-, 2000

      26 W. T. The, 35 : 817-, 1987

      27 Y. Shao, 15 : 5061-, 2007

      28 J. Vinsova, 7 : 12-, 2008

      29 A. P. Kurtz, 35 : 106-, 1987

      30 A. P. Kurtz, 35 : 115-, 1987

      31 S. S. Patil, 124 : 1043-, 2012

      32 S. Gattinoni, 20 : 4406-, 2010

      33 S. Y. Sit, 20 : 1272-, 2010

      34 J. S. Norwick, 57 : 7364-, 1992

      35 P. Majer, 59 : 1937-, 1994

      36 R. Batey, 39 : 6267-, 1998

      37 S. Cenini, 53 : 1243-, 1988

      38 F. Ragaini, 13 : 1178-, 1994

      39 F. Paul, 17 : 2199-, 1998

      40 B. Wan, 183 : 81-, 1999

      41 J. Yadav, 39 : 3259-, 1998

      42 X. Ariza, 40 : 7515-, 1999

      43 A. Inesi, 63 : 1337-, 1998

      44 V. Baliah, 23 : 264-, 1954

      45 C. R. Noller, 70 : 3853-, 1948

      46 M. Balasubramanian, 19 : 2135-, 1963

      47 M. Uma, 19B : 74-, 1980

      48 R. T. McBurney, 135 : 7349-, 2013

      49 G. Bertolini, 63 : 6031-, 1998

      50 K. Zhang, 18 : 4667-, 2016

      51 D. K. Hutchinson, 3 : 1021-, 2003

      52 R. Ouellet, 27 : 509-, 1984

      53 P. Jager, "Ullmann’s Encyclopedia of IndustrialChemistry" VCH 51-, 1986

      54 T. W. Greene, "Protective Groups in Organic Synthesis" Wiley & Sons 175-, 1997

      55 S. W. Pelletier, "Chemical and Biological Perspectives, Vol. 10" Elsevier Science Ltd 155-, 1996

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2008-01-01 평가 SCI 등재 (기타) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-07-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.58 0.11 0.38
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.28 0.23 0.213 0.04
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼